Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Thoracic 1Sarcoma 1Gynecologic 1Breast 1

Conditions

Sarcoma 17Liposarcoma 3Sarcoma, Ewing 2Rhabdomyosarcoma 2Prostatic Neoplasms 2Ovarian Neoplasms 2Leiomyosarcoma 2Breast Neoplasms 2Solitary Fibrous Tumors 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasm Metastasis 1Melanoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangioendothelioma, Epithelioid 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Nivolumab 5Magnetic Resonance Spectroscopy 5Specimen Handling 4pembrolizumab 2Ipilimumab 2Immunoglobulin G 2tislelizumab 1temsirolimus 1spartalizumab 1sargramostim 1regorafenib 1pemigatinib 1eribulin 1cabozantinib 1brivanib 1avelumab 1X-Rays 1Valproic Acid 1Sirolimus 1Radiosurgery 1Mifepristone 1Fluorodeoxyglucose F18 1FAPI-46 1Docetaxel 1Disulfides 1Cyclophosphamide 1Cryosurgery 1Colony-Stimulating Factors 1Clinical Trials, Phase II as Topic 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Transitional Cell × eribulin × Sarcoma × Clear all
NCT02014337 2018-01-17

Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors

Corcept Therapeutics

Phase 1 Completed
37 enrolled
BreastGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡